Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab for Cachexia in COPD
NCT00244192Phase 2Completed
- Sponsor
- CIRO
- Start
- Oct 2003
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of infliximab in cachexia, sponsored by CIRO. Started Oct 2003; status: completed.
02
Drugs
infliximab
03
Conditions
cachexia
Beyond the preview
Go deeper on NCT00244192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00244192.